@wesstreeting@DHSCgovuk As a Gleason 4+3 survivor, I’m proof MRI-first pathway works. The UKNSC 2025 proposal is too narrow. Don’t let clinical success like mine be lost.’ Early detection saved your life and mine - make it the standard. @PCR_News (Prostate Cancer Research)
@PCR_News What a backward step and risk to life! If that had been the situation about 6 years ago a PSA test may have been denied to me. Even after a Prostatectomy my PSA is beginning to rise again. Unbelievable!
The Department of Health and Social Care has confirmed that the Prostate Cancer Risk Management Programme (PCRMP) has been withdrawn.
We take a look at what has changed and the questions that remain about PSA testing guidance. Read more on our website: https://t.co/EwWqS239h5
A needed and most welcome update on the PSA debate via https://t.co/vYwhzGcXoE: The PSA test isn't "broken"—blind mass screening was. When used selectively with proper pre-test preparation and backed by pre-biopsy mpMRI & Active Surveillance, the PSA pathway remains a life-saving tool. Know your personal risk profile! 🩺#ProstateCancer #HealthAwareness
UK Government accepted the National Screening Committee’s recommendation against national prostate cancer screening on 2 June 2026.
17 days earlier, Cochrane published the definitive review on that exact question.
Two dates. Cochrane’s own words. A short thread. 🧵
The medical community has a perception that breast cancer screening GOOD and prostate cancer screening BAD. Internist Gil Welch provides data showing just how flawed that perception is.
Last month, we took a trip to @imperialcollege to visit Dr Claire Fletcher and her team whose research is supported by a co-sponsored award from Prostate Cancer Research and @WorldwideCancer.
If national policy fails us, it's time for a grassroots work-around. The NSC didn't ban testing—the PCRMP still gives every man over 50 the right to request a free PSA check. We must use local PPGs & PCNs to inform men & bypass this gatekeeping. Local UDI starts now! (3/3)
The real harm? Over 10,000 men diagnosed at metastatic Stage 4 each year, facing incurable disease. Modern screening cuts mortality by 20-30%—meaning the NSC is leaving up to 3,600 avoidable deaths on the table annually. We cannot just let this disease fester. (2/3)
The UK NSC’s decision to limit prostate cancer screening to just a few thousand BRCA2 carriers is deeply frustrating. Diagnosed with an aggressive Gleason 4+3 in 2020 with ZERO family history, I know firsthand that a narrow policy leaves the silent majority exposed. (1/3)
A disappointing decision from the UK NSC published today.
But the model stays alive, and so does this campaign.
We’ll keep working to strengthen the case. Because men deserve it.
Read our full statement: https://t.co/8N3BxgmRo2
Three of my uncles died from prostate cancer. Don’t risk cutting back on screening https://t.co/1yjjBhp8Mh
These tragedies could be prevented if UK screening moved with the times - not relying on old data. Failure to detect also leads to metastatic cancer, the drugs for which are vastly expensive and impose a major cost legacy on Primary Care. Act asap. @nandwics
I was lucky, and still surviving, in spite of UK's lack of screening. @Telegraph
Before It Becomes Dangerous https://t.co/mbCN9RcyP2
Thank you to Dr. Chabert of "The Prostate Clinic" (Australia) simply explaining how, from the ERSPC Study, a new era is blossoming - "MRI is a Game Changer". "Age is the strongest risk factor" - I know, that's me!
The APPG on Prostate Cancer has published its latest report on diagnosing prostate cancer, highlighting that primary care needs to be given clearer direction and support to tackle the variation in practice that is letting too many people down.
Read more: https://t.co/YiYv84Mppv
Please ensure that Prostate Cancer Screening and diagnosis in the UK are revolutionised in order that we can catch up with those such as Australia and various EU Countries who will now follow an “optimal” approach, potentially leaving the UK using 10-year old thinking.
@ProstatePathway